Immunogenicity and Safety of a Live Attenuated Zoster Vaccine (ZOSTAVAX™) in Korean Adults

A live attenuated zoster vaccine (ZOSTAVAX™, Merck & Co., Inc.) was approved by the Korea Ministry of Food and Drug Safety in 2009. However, the immunogenicity and safety of the vaccine has not been assessed in Korean population. This is multi-center, open-label, single-arm study performed with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Korean Med Sci
Hauptverfasser: Choi, Won Suk, Choi, Jung-Hyun, Choi, Jun Yong, Eom, Joong Sik, Kim, Sang Il, Pai, Hyunjoo, Peck, Kyong Ran, Sohn, Jang Wook, Cheong, Hee Jin
Format: Artigo
Sprache:Inglês
Veröffentlicht: The Korean Academy of Medical Sciences 2016
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4712571/
https://ncbi.nlm.nih.gov/pubmed/26770032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2016.31.1.13
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge